These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1154320)
1. Summary report and recommendations of the task force members and consultants. Ménachd ; Roberts HR Thromb Diath Haemorrh; 1975 Jun; 33(3):645-7. PubMed ID: 1154320 [No Abstract] [Full Text] [Related]
2. Serologic evidence of hepatitis B virus infection in patients with hemophilia B. a multicenter study. Hoofnagle JH; Aronnon D; Roberts H Thromb Diath Haemorrh; 1975 Jun; 33(3):606-9. PubMed ID: 1154315 [TBL] [Abstract][Full Text] [Related]
3. Post-transfusion hepatits following the use of prothrombin complex concentrates. Roberts HR; Blatt PM Thromb Diath Haemorrh; 1975 Jun; 33(3):610-6. PubMed ID: 1154316 [No Abstract] [Full Text] [Related]
4. Steps toward improved safety of treatment in hemophilia B. Goldsmith JC J Lab Clin Med; 1993 Mar; 121(3):370-1. PubMed ID: 8445281 [No Abstract] [Full Text] [Related]
5. Factor IX concentrates for clinical use. Thompson AR Semin Thromb Hemost; 1993; 19(1):25-36. PubMed ID: 8456321 [No Abstract] [Full Text] [Related]
6. [Clinical use of factor IX concentrates]. Nyman D Schweiz Med Wochenschr; 1975 Sep; 105(37):1188-90. PubMed ID: 1215901 [TBL] [Abstract][Full Text] [Related]
7. Transfusion support for haemophiliacs. Allain JP Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835 [No Abstract] [Full Text] [Related]
8. Current management of hemophilia B. Roberts HR; Eberst ME Hematol Oncol Clin North Am; 1993 Dec; 7(6):1269-80. PubMed ID: 8294316 [TBL] [Abstract][Full Text] [Related]
9. Virus safety of pasteurized factor VIII and factor IX concentrates: study in virgin patients. Heimburger N; Karges HE; Weidmann E Dev Biol Stand; 1987; 67():303-10. PubMed ID: 3038638 [TBL] [Abstract][Full Text] [Related]
10. Jaundice and hepatitis B antigen-antibody in hemophilia. Lewis JH; Maxwell NG; Brandon JM Transfusion; 1974; 14(3):203-11. PubMed ID: 4835949 [No Abstract] [Full Text] [Related]
13. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia. McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730 [TBL] [Abstract][Full Text] [Related]
14. Specific therapy in hemophilia. Hutaff LW N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809 [No Abstract] [Full Text] [Related]
15. [Hepatitis in hemophilia]. Eggeling B; Sennekamp J; Brackmann HH; Werner I Schweiz Med Wochenschr; 1974 Sep; 104(36):1250-5. PubMed ID: 4445853 [No Abstract] [Full Text] [Related]
16. [Advances in the field of hemophilia therapy]. Loeliger EA; Veltkamp JJ Ned Tijdschr Geneeskd; 1968 Sep; 112(36):1593-5. PubMed ID: 5680135 [No Abstract] [Full Text] [Related]